Radiology, Vol 191, 639-646, Copyright © 1994 by Radiological Society of North America

ARTICLES

Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine

SH Heywang-Kobrunner, J Haustein, C Pohl, R Beck, B Lommatzsch, M Untch and WB Nathrath
Department of Radiology, University of Halle, Germany.

PURPOSE: To optimize detection and diagnosis of breast lesions with contrast-enhanced magnetic resonance (MR) imaging. MATERIALS AND METHODS: A three-dimensional fast low-angle shot pulse sequence was used for a group comparison consisting of 76 high-dose (0.16 mmol gadopentetate dimeglumine per kilogram of body weight) and 76 low-dose (0.1 mmol/kg) examinations. Intraindividual comparisons were possible in a subgroup of 20 patients. RESULTS: Enhancement with the high dose was about 1.5 times higher for benign and malignant tissues. With the lower dose, no false-positive findings could be avoided and definition of a threshold that excluded false-negative findings was problematic. Conspicuity of malignant lesions was much improved with the higher dose (a good to excellent rating in 81% vs 26% with the lower dose). Three small foci were visible only with the higher dose. CONCLUSION: The higher dose of contrast material allowed much better results. Dose comparison studies are also recommended for other techniques.

This article has been cited by other articles:

				C. Kuhl The Current Status of Breast MR Imaging * Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice Radiology, August 1, 2007; 244(2): 356 - 378. [Abstract] [Full Text] [PDF]

				C. Dromain, C. Balleyguier, S. Muller, M.-C. Mathieu, F. Rochard, P. Opolon, and R. Sigal Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. Am. J. Roentgenol., November 1, 2006; 187(5): W528 - W537. [Abstract] [Full Text] [PDF]

				M. A. Jacobs, P. B. Barker, D. A. Bluemke, C. Maranto, C. Arnold, E. H. Herskovits, and Z. Bhujwalla Benign and Malignant Breast Lesions: Diagnosis with Multiparametric MR Imaging Radiology, October 1, 2003; 229(1): 225 - 232. [Abstract] [Full Text] [PDF]

				M. V. Knopp, M. W. Bourne, F. Sardanelli, M. N. Wasser, L. Bonomo, C. Boetes, M. Muller-Schimpfle, M. A. Hall-Craggs, B. Hamm, A. Orlacchio, et al. Gadobenate Dimeglumine-Enhanced MRI of the Breast: Analysis of Dose Response and Comparison with Gadopentetate Dimeglumine Am. J. Roentgenol., September 1, 2003; 181(3): 663 - 676. [Abstract] [Full Text] [PDF]

				S. G. Orel and M. D. Schnall MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer Radiology, July 1, 2001; 220(1): 13 - 30. [Abstract] [Full Text] [PDF]

				D. Weinstein, S. Strano, P. Cohen, S. Fields, J. M. Gomori, and H. Degani Breast Fibroadenoma: Mapping of Pathophysiologic Features with Three-Time-Point, Contrast-enhanced MR Imaging—Pilot Study Radiology, January 1, 1999; 210(1): 233 - 240. [Abstract] [Full Text]